Journal:
:iranian journal of neurology
0
mohaddeseh behjati department of cardiology, school of medicine, cardiovascular research center and heart failure research center, isfahan cardiovascular research institute, isfahan university of medical sciences, isfahan, iran.
masoud etemadifar department of neurology, school of medicine, isfahan university of medical sciences, isfahan, iran.
morteza abdar esfahani department of cardiology, school of medicine, isfahan university of medical sciences, isfahan, iran.
multiple sclerosis (ms) is a chronic auto-immune disease. most therapeutic strategies for treatment of this disease direct immune modulation and control of inflammatory processes. first-line therapeutic agents showed moderate efficacy and frequent side-effects with moderate efficacy in trials. their parental administration and limited long-term adherence restrict their efficacy compared with se...
